Sensor-based Assessment and Rehabilitation of Balance in Neurological Diseases

NCT04874051 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-03-22

No results posted yet for this study

Summary

Balance impairment is one of the most common disorders due to a neurological diseases. Sensor-based technologies may be useful for falls prevention and balance recovery during patients hospitalization. OAK Elderly Care System (Khymeia Group, Noventa Padovana, Italy) allows the assessment of fall risk, the centre of pressure and the execution of balance exercises in a virtual environment.

Conditions

Interventions

DEVICE

Experimental Group

The experimental treatment will be provided by means of the OAK system. This device consists of 1 cabinet with 2 independent balance boards, 2 monitors (one for the physiotherapist and one for the patient) and 3 wireless IMUs (one for the left lower limb, one for the right lower limb and one for the trunk). The 2 balance boards provide body weight transfer exercises, while the wireless motion sensors provide one leg stance exercises or trunk exercises in a virtual environment.

OTHER

Control Group

The Control Group will perform conventional balance exercises similar to the exercises provided with the OAK system.

Sponsors & Collaborators

  • IRCCS San Raffaele

    collaborator OTHER
  • Istituti Clinici Scientifici Maugeri SpA

    collaborator OTHER
  • IRCCS National Neurological Institute "C. Mondino" Foundation

    collaborator OTHER
  • I.R.C.C.S. Fondazione Santa Lucia

    collaborator OTHER
  • IRCCS San Camillo, Venezia, Italy

    lead OTHER

Principal Investigators

  • Andrea Turolla, PhD · San Camillo IRCCS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-02
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04874051 on ClinicalTrials.gov